UNDER DILIP SHANGHVI, Sun Pharmaceutical Industries Limited, India’s largest pharma company, is building additional engines of growth with an eye on the future, especially the specialty business, even as it simultaneously focusses on making the organisation more efficient and profitmaking. The 67-year-old Managing Director of Sun Pharma, in a rare interview and an exclusive one with BT, talks about his vision for the company, the strategy for success, new targets and the way forward. Edited excerpts:
What is your vision for the company and where is it headed?
I don’t have the ability to predict the long-term future because there are a large number of variables. However, our focus has always been that each of our businesses should focus on improving its performance over what we did last year. If I look at our major businesses—India, global specialty, and
